The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) primarily accredits health care organizations against broad-based standards of performance.
However, it has a role in postmarketing drug surveillance, specifically in terms of how health care organizations accredited by the Joint Commission review and respond to significant adverse drug events (ADEs) that occur in their organization.
This paper discusses the role of the Joint Commission in reducing the incidence and severity of ADEs.
Mots-clés Pascal : Médicament, Toxicité, Erreur, Prescription médicale, Pharmacovigilance, Accréditation, Hôpital, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Drug, Toxicity, Error, Medical prescription, Pharmacovigilance, Accreditation, Hospital, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0125436
Code Inist : 002B02A06. Création : 16/11/1999.